Skip to content

Other ways to search: Events Calendar | UTHSC News

College of Pharmacy Research

Apply today!

The College of Pharmacy research enterprise is characterized by a wide diversity in activities. It comprises all research areas relevant for drug discovery, preclinical and clinical development through drug utilization, outcome research and clinical research targeted at refinement of applied pharmacotherapy. Specific areas of expertise are focused in the areas of pediatrics, infectious diseases, cancer chemotherapy, and cardiovascular and metabolic diseases.

Thus, the College harbors the comprehensive expertise to address research questions throughout the life cycle of a drug, from its early stages as a potential drug candidate up to its clinical use in patient subpopulations.

The College’s breadth of research activities is matched by a diverse and balanced portfolio of external funding sources including federal and state agencies, foundations and commercial entities.

 

Pharmacy Faculty Research Interests

Hassan Almoazen, PhD
Director of PhD Program
Associate Professor
Department of Pharmaceutical Sciences

halmoaze@uthsc.edu

  • Oral and transdermal drug delivery
  • Drug solubility enhancement
  • Drug stability enhancement
  • Drug permeability enhancement
  • Pediatric drug delivery
Sarka Beranova-Giorgianni, PhD
Associate Professor
Department of Pharmaceutical Sciences

sberanov@uthsc.edu

  • Proteomics
  • Biomarker and drug target discovery
  • Retinal diseases
  • Oxidative stress
  • Biological mass spectrometry
Daniel M. Collier, PhD
Assistant Professor
Department of Pharmaceutical Sciences

daniel-collier@uthsc.edu

  • Traumatic brain injury (TBI)
  • Cardiovascular disease
  • Calcium signaling
  • Genetically-encoded calcium indicators
  • High-resolution 4D microscopy
Ted Cory, PharmD, PhD
Assistant Professor
Department of Clinical Pharmacy and Translational Science

tcory1@uthsc.edu

  • HIV
  • Cellular reservoirs of HIV
  • Drug efflux transporters
  • Macrophages
  • P-glycoprotein
Jarrod Fortwendel, PhD
Associate Professor
Department of Clinical Pharmacy and Translational Science

jfortwen@uthsc.edu

  • Fungal pathogenesis
  • Antifungal drug resistance
  • Antifungal drug efficacy
  • CRISPR/Cas9-based gene editing
  • Fungal genetics
Maxwell Gyamfi, PhD
Assistant Professor
Department of Pharmaceutical Sciences

mgyamfi@uthsc.edu

  • Alcoholic liver disease
  • Obesity/nonalcoholic fatty liver disease
  • Nuclear receptors
  • Type 2 diabetes
  • Gut microbiome
Kirk Hevener, PharmD, PhD
Assistant Professor
Department of Pharmaceutical Sciences

khevener@uthsc.edu

  • Infectious disease
  • Antibacterial design
  • Structural biology
  • Computer-aided drug design
  • Protein biochemistry
Camaron Hole, PhD
Assistant Professor
Department of Clinical Pharmacy and Translational Science

chole@uthsc.edu

  • Fungal pathogenesis
  • Fungal immunology
  • Innate immunity
  • Cryptococcosis
  • Pulmonary infections
Jianxiong Jiang, MS, PhD
Associate Professor
Department of Pharmaceutical Sciences

jjiang18@uthsc.edu

  • Prostaglandin signaling
  • G protein-coupled receptors
  • Neuroinflammation
  • Blood-brain barrier
  • Chemical neuroscience
Michio Kurosu, PhD
Professor
Department of Pharmaceutical Sciences

mkurosu@uthsc.edu

  • Natural products
  • Drug discovery
  • Organic chemistry
  • Antibacterial
  • Anti-cancer
M. Dennis Leo, PhD
Assistant Professor
Department of Pharmaceutical Sciences

mleo@uthsc.edu

  • Cardiovascular disease
  • Obesity/Type 2 diabetes
  • Cell signaling
  • Protein trafficking
  • Epigenetics
Wei Li, PhD
Director of UTHSC COP Drug Discovery Center
Distinguished Professor
Department of Pharmaceutical Sciences

wli@uthsc.edu

  • Small molecule drug discovery
  • Medicinal chemistry
  • Cancer biology
  • Computer-aided drug design
  • Organic synthesis
Bernd Meibohm, PhD, FCP, FAAPS
Associate Dean, Graduate Programs and Research
Professor and Chair
Department of Pharmaceutical Sciences

bmeibohm@uthsc.edu

  • Pharmacometrics
  • Pharmacokinetic/Pharmacodynamic modeling
  • Anti-infective drug discovery and development
  • Therapeutic protein PK/PD
  • Pediatric clinical pharmacology
Duane Miller, PhD
Professor Emeritus
Department of Pharmaceutical Sciences

dmiller@uthsc.edu

  • Medicinal chemistry
  • Organic synthesis of small drug molecules
  • Tubulin inhibitors for cancer treatment
  • Androgen agonists and antagonists
  • Drugs for glioblastoma and other brain cancers
Bob Moore, PhD
Professor
Department of Pharmaceutical Sciences

bmoore@uthsc.edu

  • Development of novel agonists and inverse agonists of cannabinoid receptor 2
  • Signaling pathways of cannabinoid receptor 1 in the central nervous system
  • Molecular modeling
  • Synthetic chemistry
  • Pharmacological evaluation of new compounds
Glen Palmer, PhD
Associate Professor
Department of Clinical Pharmacy and Translational Science

gpalmer5@uthsc.edu

  • Infectious fungi
  • Mechanisms of fungal pathogenesis
  • Antifungal discovery
  • Antifungal drug resistance
Frank Park, PhD
Associate Professor
Department of Pharmaceutical Sciences

fpark@uthsc.edu

  • Acute kidney injury
  • Epithelial cell regeneration
  • G-protein regulators
  • SIgnal transduction
  • Lentiviral vectors
Brian Peters, PhD
Associate Professor
Department of Clinical Pharmacy and Translational Science

bpeter21@uthsc.edu

  • Mucosal candidiasis
  • Innate immunity and inflammation
  • Polymicrobial interactions
  • Microbial genetics
  • Drug repurposing
Georgi Petkov, PhD
Professor
Department of Pharmaceutical Sciences

gpetkov@uthsc.edu

  • Electrophysiology
  • Ion channels
  • Smooth muscle
  • Urology research
  • Urinary bladder function and regulation
Udai Singh, PhD
Associate Professor
Department of Pharmaceutical Sciences

usingh1@uthsc.edu

  • Inflammation (mucosal and bladder)
  • Obesity and metabolic disease
  • Alternative medicine
  • Autoimmune diseases
  • Innate immunity
Bhupesh Singla, PhD
Assistant Professor
Department of Pharmaceutical Sciences

bsingla@uthsc.edu

  • Vascular calcification
  • Cardiovascular disease
  • Atherosclerosis
  • Lymphanogiogenesis
  • Cholesterol efflux
Chalet Tan, PhD
Professor
Department of Pharmaceutical Sciences

ctan5@uthsc.edu

  • Targeted drug discovery
  • Immunotherapy
  • Cancer biology and therapeutics
  • PK/PD
  • Nanomaterials
Chao-Yie Yang, PhD
Associate Professor
Department of Pharmaceutical Sciences

cyang26@uthsc.edu

  • Structure-based drug design and development
  • Cancer therapeutic development
  • Immune-mediated diseases and disorders
  • Targeting RNA splicing factors in cancers
  • Computational modeling and simulation

 

Mar 3, 2023